Related Experiment Video
Updated: Jun 19, 2026
Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Published on: February 23, 2024
Metachromatic leukodystrophy: a scoring system for brain MR imaging observations
1Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. feichler@partners.org
Background And Purpose:
Metachromatic leukodystrophy (MLD) is a devastating demyelinating disease for which novel therapies are being tested. We hypothesized that MR imaging of brain lesion involvement in MLD could be quantified along a scale.
Materials And Methods:
Thirty-four brain MR images in 28 patients with proved biochemical and genetic defects for MLD were reviewed: 10 patients with late infantile, 16 patients with juvenile, and 2 patients with adult MLD. All MR images were reviewed by experienced neuroradiologists and neurologists (2 readers in Germany, 2 readers in the United States) for global disease burden, as seen on the T2 and fluid-attenuated inversion recovery images. A visual scoring method was based on a point system (range, 0-34) derived from the location of white matter involvement and the presence of global atrophy, analogous to the scoring system developed for adrenoleukodystrophy. The readers were blinded to the neurologic findings.
Results:
Thirty-three of 34 MR images showed confluent T2 hyperintensities of white matter. The inter-rater reliability coefficient was 0.988. Scores between readers were within 2 points of each other. Serial MR imaging studies in 6 patients showed significant progressive disease in 3 patients (initial score average, 4; mean follow-up, 24.3) and no change or 1 point progression in 3 patients (initial score average, 12; mean follow-up, 12.66). Projection fibers and the cerebellum tended to be involved only in advanced stages of disease.
Conclusions:
The MLD MR severity scoring method can be used to provide a measure of brain MR imaging involvement in MLD patients.
Insights
A new scoring method quantifies brain involvement in metachromatic leukodystrophy (MLD) using MR imaging. This tool aids in assessing disease progression and severity in MLD patients.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Metachromatic leukodystrophy (MLD) is a severe demyelinating disease.
- Novel therapeutic strategies for MLD are under investigation.
- Quantifying disease burden is crucial for treatment evaluation.
Purpose of the Study:
- To develop and validate a quantitative MR imaging scoring system for brain involvement in MLD.
- To assess the reliability of the proposed scoring method.
Main Methods:
- Review of 34 brain MR images from 28 MLD patients (late infantile, juvenile, adult).
- Experienced neuroradiologists and neurologists applied a visual scoring system (0-34 points) based on white matter lesions and atrophy.
- Readers were blinded to clinical data.
Main Results:
- High inter-rater reliability (0.988) was achieved with scores differing by a maximum of 2 points.
- Confluent white matter hyperintensities were observed in 33 of 34 MR images.
- Serial imaging in 6 patients demonstrated disease progression in 3 and stability in 3, correlating with initial scores.
Conclusions:
- The developed MR imaging severity scoring method effectively measures brain involvement in MLD.
- This quantitative tool can aid in monitoring disease progression and treatment response in MLD.
